Business Standard

Pharma shares in focus; Divi's Labs hits new high, Gland Pharma zooms 20%

Dishman Carbogen Amcis, Ipca Lab, SPARC, Caplin Point Laboratories, Dr. Lal PathLabs and Granules India from the S&P BSE Healthcare index were up in the range of 4 per cent to 5 per cent on the BSE

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Premium

According to virologists, there are four phases to developing a vaccine.

SI Reporter Mumbai
Shares of pharmaceutical companies were trading actively on Monday with the newly listed Gland Pharma freezing in the 20 per cent upper circuit while Divi's Laboratories hit a record high on the BSE on investors' renewed buying interest.

Dishman Carbogen Amcis, Ipca Laboratories, Sun Pharma Advanced Research Company (SPARC), Caplin Point Laboratories, Dr. Lal PathLabs and Granules India from the S&P BSE Healthcare index were up in the range of 4 per cent to 5 per cent on the BSE. Meanwhile, the S&P BSE Healthcare index, the top gainer among sectoral indices, was up 1.7 per cent as compared to 0.17

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 23 2020 | 10:52 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com